Press Releases

Structure-based Drug Design is an Essential Tool for Quicker and More Cost-Efficient Lead Discovery

With the aid of artificial intelligence and AI-based sophisticated machine learning technology, data processing has become much easier, which greatly eases burdens for researchers,” said a senior scientist from Alfa Chemistry.

CPHI 2022: ‘Gut microbiome therapy to be approved in the next two years’

#CPHI22: ‘Expert warns psychedelic approvals alone not a panacea for patients’

Recipharm bolsters blow fill seal capabilities with Lab+

Invests in a new high speed filling line for pre-filled syringes and cartridges at its facility in Wasserburg.

Emmes rapidly expands in India – driven by deep vaccines and infectious diseases expertise and enhanced study startup capabilities

Celebrating the role of Genetic Counsellors in healthcare

Genomics England, The British Society for Genetic Medicine (BSGM) and the Association of Genetic Nurses and Counsellors, are all joining forces to celebrate the expertise of genetic counsellors on Genetic Counsellor Awareness Day — Thursday 10 November 2022.

Rho Appoints Clinical Oncologist and Industry Veteran J. Marc Pipas, MD, As Senior Medical Director

Dr. Pipas’ Experience Enhances Rho’s Oncology Capabilities

Next-generation of qPCR Reagents Push the Boundaries of Performance

PCR Biosystems has launched a new family of qPCR reagents mixes: Clara™ Probe Mix, Clara™ Probe 1-Step Mix and Clara™ HRM Mix.

Inizio expands senior leadership team with key appointment

Quanticate announces plans to accelerate growth in North America

Calyx Advanced IRT Automation Saving Sponsors Time and Money

Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste

New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference

A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.

Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place

The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.

Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D

BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.

CD ComputaBio Introduces Four Docking Software for Drug Development

Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions

Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services

Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service

medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials. Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.

Jumo Health Honored in Inc.’s Inaugural Power Partner Awards

Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.